Subtype
Testicular Neoplasm
CI-CAN-00004087Explore in graph →
Non-malignant50 active trials3 approved drugs
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00004087Explore in graph →
Clinical trials
286 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02478502 | Testis CAB: Cabazitaxel as Salvage Treatment for Cisplatin-resistant Germ Cell Cancer | terminated | Phase 2 | 14 | University Hospital, AkershusOTHER | 4 | Feb 2, 2024 | clinicaltrials |
| NCT01769222 | Ipilimumab and Local Radiation for Selected Solid Tumors | terminated | Phase 1 | 3 | Stanford UniversityOTHER | 1 | Jan 24, 2024 | clinicaltrials |
| NCT06133699 |
| Sentinel Lymph Node Biopsy in Stage AI-IIA Germ Cell Tumors(PITERLAND) |
| unknown |
| N/A |
| 44 |
| N.N. Petrov National Medical Research Center of OncologyOTHER |
| 1 |
| Jan 3, 2024 |
| clinicaltrials |
| NCT05063760 | Exercise in Testicular Germ Cell Cancer Survivors(ExCell) | unknown | N/A | 60 | Slovak Academy of SciencesOTHER_GOV | 1 | Dec 5, 2023 | clinicaltrials |
| NCT06142500 | WEST-KOaST Study: WES Analysis of Testicular Cancer Patientsand Their First-degree Family Members(West-KOaSt) | not yet recruiting | N/A | 4,500 | IRCCS San RaffaeleOTHER | 0 | Nov 21, 2023 | clinicaltrials |
| NCT05899361 | A Novel Imaging Protocol in Use to Identify Lymph Nodes and Organs of Interest | recruiting | N/A | 10 | Dana-Farber Cancer InstituteOTHER | 1 | Oct 24, 2023 | clinicaltrials |
| NCT06044220 | Testicular Self-examination Training Given to Students | completed | N/A | 100 | Karabuk UniversityOTHER | 1 | Sep 25, 2023 | clinicaltrials |
| NCT00788125 | Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid Tumors | terminated | Phase 1 / Phase 2 | 7 | City of Hope Medical CenterOTHER | 1 | Jul 14, 2023 | clinicaltrials |
| NCT05928377 | Unveiling Patient Experiences in Testicular Cancer Clinical Trials | unknown | — | 500 | Power Life Sciences Inc.INDUSTRY | 1 | Jul 3, 2023 | clinicaltrials |
| NCT00003518 | Paclitaxel Plus Gemcitabine in Treating Patients With Refractory Metastatic Germ Cell Tumors | completed | Phase 2 | 44 | Eastern Cooperative Oncology GroupNETWORK | 2 | Jun 22, 2023 | clinicaltrials |
| NCT00003800 | Diagnostic Study of Patients With Stage I Testicular Cancer | completed | N/A | 76 | Eastern Cooperative Oncology GroupNETWORK | 1 | Jun 22, 2023 | clinicaltrials |
| NCT01684098 | Safety and Efficacy of FalateScan (Technetium Tc 99m EC20) in Patients With Known Suspected Recurrent or Metastatic Cancer From a Solid Tumor | completed | Phase 2 | 40 | EndocyteINDUSTRY | 0 | Jun 22, 2023 | clinicaltrials |
| NCT00002520 | Physician-Initiated Stop-Smoking Program for Patients Receiving Treatment for Early-Stage Cancer | completed | N/A | 434 | Eastern Cooperative Oncology GroupNETWORK | 1 | Jun 15, 2023 | clinicaltrials |
| NCT05840575 | Investigating Cognitive Impairment in Young Patients With Cancer Prospectively(MyBrain) | recruiting | — | 100 | Rigshospitalet, DenmarkOTHER | 1 | May 3, 2023 | clinicaltrials |
| NCT05670938 | Follow-up After Surgery for Testicular Cancer(FUTURE-testis) | recruiting | — | 145 | Erasmus Medical CenterOTHER | 1 | Feb 23, 2023 | clinicaltrials |
| NCT05244577 | Olanzapine Combined With Fosaprepitant, Ondansetron, and Dexamethasone for Preventing Nausea and Vomiting in Patients With Testicular Cancer | unknown | Phase 3 | 75 | Shi YanxiaOTHER | 1 | Feb 6, 2023 | clinicaltrials |
| NCT04180033 | Diagnostic Yield of Colonoscopy Surveillance in Testicular Cancer Survivors Treated With Platinum-based Chemotherapy(CATCHER) | completed | N/A | 154 | The Netherlands Cancer InstituteOTHER | 1 | Jan 31, 2023 | clinicaltrials |
| NCT02643303 | A Study of Tremelimumab and IV Durvalumab Plus Poly-ICLC in Subjects With Biopsy-accessible Cancers | completed | Phase 1 / Phase 2 | 58 | Ludwig Institute for Cancer ResearchOTHER | 1 | Dec 2, 2022 | clinicaltrials |
| NCT05056688 | Effect of Online Education Given to Young Adults on Testicular Cancer Health Beliefs and Behaviors | completed | N/A | 90 | Agri Ibrahim Cecen UniversityOTHER | 1 | Oct 10, 2022 | clinicaltrials |
| NCT04935255 | Determining the Clinical Relevance of the inTeraction Between AprepitaNt aNd EtoposiDe(TANNED) | completed | — | 17 | Radboud University Medical CenterOTHER | 1 | Sep 10, 2022 | clinicaltrials |
| NCT04914026 | MicroRNA as Markers in Testicular Cancer | recruiting | — | 350 | Haukeland University HospitalOTHER | 2 | Aug 8, 2022 | clinicaltrials |
| NCT02499952 | Pembrolizumab in Subjects With Incurable Platinum-Refractory Germ Cell Tumors | terminated | Phase 2 | 12 | Nasser Hanna, M.D.OTHER | 1 | Jul 11, 2022 | clinicaltrials |
| NCT05083143 | The Impact of the COVID-19 Pandemic on Testicular Cancer | completed | — | 50 | Ankara Training and Research HospitalOTHER | 1 | Apr 27, 2022 | clinicaltrials |
| NCT02994758 | Development of Diagnostics and Treatment of Urological Cancers(DEDUCER) | unknown | N/A | 100 | Helsinki University Central HospitalOTHER | 1 | Mar 11, 2022 | clinicaltrials |
| NCT03436901 | Whole Body MRI With DWI for Monitoring Patients Treated for Testicular Cancer Stage II-III(TENY) | completed | N/A | 90 | Aarhus University HospitalOTHER | 1 | Jan 3, 2022 | clinicaltrials |
| NCT05073198 | The Effect of the Brochure on Testicular Self-Exam | completed | N/A | 92 | Selcuk UniversityOTHER | 1 | Oct 11, 2021 | clinicaltrials |
| NCT01805037 | Brentuximab Vedotin + Rituximab as Frontline Therapy for Pts w/ CD30+ and/or EBV+ Lymphomas | terminated | Phase 1 / Phase 2 | 20 | Northwestern UniversityOTHER | 1 | Sep 1, 2021 | clinicaltrials |
| NCT00053352 | Surgery and Combination Chemotherapy in Treating Children With Extracranial Germ Cell Tumors | completed | Phase 3 | 302 | Children's Oncology GroupNETWORK | 6 | Jul 13, 2021 | clinicaltrials |
| NCT00536601 | High-Dose Chemotherapy With or Without Total-Body Irradiation Followed by Autologous Stem Cell Transplant in Treating Patients With Hematologic Cancer or Solid Tumors | completed | N/A | 174 | Roswell Park Cancer InstituteOTHER | 1 | Apr 22, 2021 | clinicaltrials |
| NCT04848545 | Endocrine Disrupting Chemical Exposure and Testicular Cancer(DISRUPT) | active not recruiting | — | 700 | Rigshospitalet, DenmarkOTHER | 1 | Apr 21, 2021 | clinicaltrials |
| NCT01678443 | Monoclonal Antibody Therapy Before Stem Cell Transplant in Treating Patients With Relapsed or Refractory Lymphoid Malignancies | terminated | Phase 1 | 2 | Fred Hutchinson Cancer CenterOTHER | 1 | Apr 2, 2021 | clinicaltrials |
| NCT01037790 | Phase II Trial of the Cyclin-Dependent Kinase Inhibitor PD 0332991 in Patients With Cancer | completed | Phase 2 | 304 | Abramson Cancer Center at Penn MedicineOTHER | 1 | Mar 11, 2021 | clinicaltrials |
| NCT02860819 | Study of Gemcitabine, Carboplatin and VELIPARIB (ABT-888) in Refractory Testicular Germ Cell Cancer | completed | Phase 2 | 15 | National Cancer Institute, SlovakiaOTHER_GOV | 1 | Mar 3, 2021 | clinicaltrials |
| NCT00002566 | Combination Chemotherapy With Bone Marrow Transplantation in Treating Men With Germ Cell Tumors | completed | Phase 3 | 280 | UNICANCEROTHER | 1 | Feb 23, 2021 | clinicaltrials |
| NCT04150848 | A Biobehavioral Intervention for Young Men With Testicular Cancer | unknown | Phase 2 | 100 | University of California, IrvineOTHER | 1 | Dec 19, 2020 | clinicaltrials |
| NCT03896958 | The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology)(PIONEER) | unknown | — | 1,000 | SpeciCareINDUSTRY | 1 | Dec 4, 2020 | clinicaltrials |
| NCT01258998 | Study of Akt Inhibitor MK2206 in Patients With Relapsed Lymphoma | completed | Phase 2 | 60 | National Cancer Institute (NCI)NIH | 1 | Nov 4, 2020 | clinicaltrials |
| NCT04122430 | Risk of Venous Thromboembolism in Patients Receiving First-Line Chemotherapy for Disseminated Germ Cell Tumours(G3 RPLN PBC) | completed | — | 1,135 | Walter and Eliza Hall Institute of Medical ResearchOTHER | 1 | Oct 19, 2020 | clinicaltrials |
| NCT02429466 | Study of the Hypomethylating Drug Guadecitabine (SGI-110) Plus Cisplatin in Relapsed Refractory Germ Cell Tumors | completed | Phase 1 | 14 | Nasser HannaOTHER | 1 | Sep 23, 2020 | clinicaltrials |
| NCT02677727 | Study of Cisplatin-Induced Peripheral Neuropathy in Patients With Germ Cell Tumor | completed | — | 54 | Costantine AlbanyOTHER | 1 | Sep 22, 2020 | clinicaltrials |
| NCT00341588 | A Case-Control Study of Testicular Germ Cell Tumors Among U.S. Military Servicemen | completed | — | 2,772 | National Cancer Institute (NCI)NIH | 1 | Aug 21, 2020 | clinicaltrials |
| NCT00342537 | Genetics of Familial Testicular Cancer | completed | — | 1,842 | National Cancer Institute (NCI)NIH | 1 | Jul 17, 2020 | clinicaltrials |
| NCT02743481 | Early Life Exposures in Agriculture | completed | — | 60,000 | National Cancer Institute (NCI)NIH | 1 | Apr 20, 2020 | clinicaltrials |
| NCT02890030 | The Platinum Study Comparison Group | completed | — | 102 | Lawrence EinhornOTHER | 1 | Apr 8, 2020 | clinicaltrials |
| NCT02991209 | Study of Testosterone vs Placebo in Testicular Cancer Survivors(Einstein) | completed | Phase 2 / Phase 3 | 69 | Mikkel BandakOTHER | 1 | Mar 6, 2020 | clinicaltrials |
| NCT00007813 | Peripheral Stem Cell Transplantation Plus Chemotherapy in Treating Patients With Malignant Solid Tumors | completed | Phase 1 | 21 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Feb 17, 2020 | clinicaltrials |
| NCT00006251 | Fludarabine Phosphate, Low-Dose Total-Body Irradiation, and Donor Stem Cell Transplant Followed by Cyclosporine, Mycophenolate Mofetil, Donor Lymphocyte Infusion in Treating Patients With Hematopoietic Cancer | completed | Phase 1 / Phase 2 | 21 | Fred Hutchinson Cancer CenterOTHER | 2 | Jan 21, 2020 | clinicaltrials |
| NCT00014235 | Fludarabine Phosphate and Total-Body Radiation Followed by Donor Peripheral Blood Stem Cell Transplant and Immunosuppression in Treating Patients With Hematologic Malignancies | completed | N/A | 160 | Fred Hutchinson Cancer CenterOTHER | 3 | Jan 21, 2020 | clinicaltrials |
| NCT00003196 | Low-Dose Total Body Irradiation and Donor Peripheral Blood Stem Cell Transplant Followed by Donor Lymphocyte Infusion in Treating Patients With Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, or Multiple Myeloma | completed | N/A | 63 | Fred Hutchinson Cancer CenterOTHER | 3 | Dec 27, 2019 | clinicaltrials |
Data updated 22 days agoSource updated Feb 2, 2024source: clinicaltrials